Effectiveness of Pharmacotherapy for Pathological Gambling: A Chart Review

References

• Shaffer HJ, Hall MN, Vander Bilt J: Estimating the preva-lence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Pub Health 1999; 89:1369–1376
   PubMed Web of Science ®Google Scholar
• Grant JE, Kim SW: Demographic and clinical features of 131 adult pathological gamblers. J Clin Psychiatry 2001; 62:957–962
   PubMed Web of Science ®Google Scholar
• Blaszczynski A, Silove D: Pathological gambling: Forensic is-sues. Aust NZ I Psychiatry 1996; 30:358–369
   PubMed Web of Science ®Google Scholar
• McCormick RA, Russo AM, Ramirez LF, Taber JI: Affec-tive disorders among pathological gamblers seeking treatment. Am J Psychiatry 1984; 141:215–218
   PubMed Web of Science ®Google Scholar
• Black DW, Moyer T: Clinical features and psychiatric comor-bidity of subjects with pathological gambling behavior. Psychi-atr Serv 1998; 49:1434–1439
   PubMed Web of Science ®Google Scholar
• Bland RC, Newman SC, Orn H, Stebelsky G: Epidemiology of pathological gambling in Edmonton. Can J Psychiatry 1993; 38:108–112
   PubMed Web of Science ®Google Scholar
• Phillips DP, Welty WR, Smith MM: Elevated suicide levels associated with legalized gambling. Suicide Life Threat Behav 1997; 27:373–378
   PubMed Web of Science ®Google Scholar
• Blanco C, Petkova E, Ibanez A, Saiz-Ruiz J: A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 2002; 14:9–15
   PubMedGoogle Scholar
• Hollander E, Frenkel M, DeCaria C, Trungold S, Stein DJ: Treatment of pathological gambling with clomipramine [letter]. Am J Psychiatry 1992; 149:710–711
   PubMed Web of Science ®Google Scholar
• Hollander E, DeCaria CM, Mari E, Wong CM, Mosovich S, Grossman R, Begaz T: Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry 1998; 155:1781–1783
   PubMed Web of Science ®Google Scholar
• Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C: A randomized double-blind fluvoxam-ine/placebo crossover trial in pathological gambling. Biol Psy-chiatry 2000; 47:813–817
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli RM: A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 2002; 63:501–507
   PubMed Web of Science ®Google Scholar
• Zimmerman M, Breen RB, Posternak MA: An open-label study of citalopram in the treatment of pathological gambling. J Clin Psychiatry 2002; 63:44–48
   PubMed Web of Science ®Google Scholar
• Crockford DN, el-Guebaly N: Naltrexone in the treatment of pathological gambling and alcohol dependence [letter]. Can J Psychiatry 1998; 43:86
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE: An open naltrexone treatment study of pathological gambling disorder. Int Clin Psychopharmacol 2001; 16:285–289
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE, Adson DE, Shin YC: Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001; 49: 914–921
   PubMed Web of Science ®Google Scholar
• Haller R, Hinterhuber H: Treatment of pathological gambling with carbamazepine [letter]. Pharmacopsychiatry 1994; 27: 129
   PubMed Web of Science ®Google Scholar
• Moskowitz JA: Lithium and lady luck: Use of lithium carbon-ate in compulsive gambling. NY State J Med 1980; 80:785–788
   PubMedGoogle Scholar
• Grant JE, Kim SW: Pharmacotherapy of pathological gam-bling. Psychiatr Ann 2001; 32:161–170
   Google Scholar
• American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: Amer-ican Psychiatric Association; 1994
   Google Scholar
• Guy W: ECDEU Assessment Manual for Psychopharmacol-ogy. U.S. Department of Health, Education and Welfare pub-lication (ADM) 76–338. Rockville, MD: National Institute of Mental Health, 1976: 218–222
   Google Scholar
• Jones SH, Thornicroft G, Coffey M, Dunn G: A brief mental health outcome scale: Reliability and validity of the Global Assessment of Functioning. Br I Psychiatry 1995; 166:654–659
   PubMed Web of Science ®Google Scholar
• Griest J, Chouinard G, DuBoff E, Halaris A, Kim S, Koran L, Liebowitz M, Lydiard R, Rasmussen S, White K: Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with OCD. Arch Gen Psychiatry 1995; 52:289–295
   Google Scholar
• Tollefson G, Rampey A, Potvin J, Jenike M, Rush A, Dominguez R, Koran L, Shear M, Goodman W, Genduso L: A multi-center investigation of fixed dose fluoxetine in the treat-ment of obsessive-compulsive disorder. Arch Gen Psychiatry 1994; 51:559–567
   PubMed Web of Science ®Google Scholar
• McElroy SL, Hudson II, Phillips KA, Keck PE, Pope HG: Clinical and theoretical implications of a possible link between obsessive-compulsive and impulse control disorders. Depres-sion 1993;1:121–132
   Google Scholar
• McElroy SL, Pope HG, Keck PE, Hudson JI, Phillips KA, Strakowski SM: Are impulse-control disorders re-lated to bipolar disorder? Compr Psychiatry 1996; 37:229–240
   PubMed Web of Science ®Google Scholar
• Hollander E, Bienstock CA, Koran LM, Pallanti S, Marazz-iti D, Rasmussen SA, Ravizza L, Benkelfat C, Saxena S, Greenberg BD, Sasson Y, Zohar J: Refractory obsessive-compulsive disorder: State-of-the-art treatment. J Clin Psy-chiatry 2002; 63(Suppl 6):20–29
   Google Scholar
• Calabrese JR, Shelton MD, Rapport DJ, Kimmel SE: Bipolar disorders and the effectiveness of novel anticonvulsants. J Clin Psychiatry 2002; 63(Suppl 3):5–9
   PubMedGoogle Scholar
• Keck PE, McElroy SL: Antiepileptic drugs for bipolar disor-der. Current Psychiatry 2002; 1(1):18–24
   Google Scholar
• Petry NM, Roll JM: A behavioral approach to understanding and treating pathological gambling. Semin Clin Neuropsych 2001; 6:177–183
   PubMedGoogle Scholar
• Ladouceur R, Sylvain C, Boutin C, Lachance S, Doucet C, Leblond J, Jacques C: Cognitive treatment of patho-logical gambling. J Nerv Ment Dis 2001; 189:774–780
   PubMed Web of Science ®Google Scholar
• Sylvain C, Ladouceur R, Boisvert JM: Cognitive and behav-ioral treatment of pathological gambling: A controlled study. J Consult Clin Psychol 1997; 65:727–732
   PubMed Web of Science ®Google Scholar
• Ninan PT, McElroy SL, Kane CP, Knight BT, Casuto LS, Rose SE: Placebo-controlled study of fluvoxamine in the treatment of patients with compulsive buying, J Clin Psychopharmacol 2000; 20:362–366
   Google Scholar
• Black DW, Gabel J, Hansen J, Schlosser S: A double-blind comparison of fluvoxamine versus placebo in the treatment of compulsive buying disorder. Ann Clin Psychiatry 2000; 12:205–211
   PubMedGoogle Scholar
• DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WT Ve-lasquez MM, Rossi JS: The process of smoking cessation: An analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psycho) 1991; 59:295–304
   PubMed Web of Science ®Google Scholar